10X XENIUM ASSAY KITS
ID: RFQ-NIAID-24-2230838Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Health and Human Services, Department of, National Institutes of Health, National Institutes of Health NIAID has issued a Combined Synopsis/Solicitation notice for the procurement of 10X Xenium Assay Kits. These kits are used for biological product manufacturing, specifically for in vitro diagnostic substances, reagents, test kits, and sets. The procurement includes specific brand name supplies for the Xenium Prime 5K Human Pan Tissue and Pathways Assay Kit, Xenium Prime 5K Add-on Custom 51 to 100 Gene Panel, and shipping and handling. The kits are essential for the Neuroimmunological Disease Section's mission to understand, diagnose, prognosticate, and cure neuroimmunological diseases. The Xenium platform instrument allows for high-resolution, imaging-based in situ spatial profiling technology, providing a single-cell resolution map of gene expression patterns within tissue sections. The place of performance is Bethesda, Maryland, United States. The procurement will be processed under FAR Part 13 Simplified Acquisition Procedures, with a small business set-aside. Interested vendors must submit their quotations through the NIAID electronic Simplified Acquisition Submission System (eSASS) website. The deadline for submission is Monday, July 29, 2024, at 11:00 AM EST.

    Point(s) of Contact
    Lifecycle
    Title
    Type
    10X XENIUM ASSAY KITS
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    STANDING ORDER FOR NOVA BIOMEDICAL LABORATORY SUPPLIES
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking quotes for a standing order of Nova Biomedical laboratory supplies. This procurement, identified by solicitation number RFQ-NIAID-24-2230810, requires specific brand-name items essential for laboratory operations, including various microsensor cards and calibrator cartridges, with a total quantity of 44 items to be delivered in multiple shipments over the next year. The selected contractor will be awarded a firm fixed-price purchase order based on technical capability and pricing, with submissions due by September 3, 2024, at 12:00 PM EST. Interested vendors should direct inquiries to Maliaka Pinkney at maliaka.pinkney@nih.gov or call 240-669-5308.
    Next-Generation Sequencing (NGS) Liquid Handling Systems – Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for two Next-Generation Sequencing (NGS) Liquid Handling Systems to enhance research capabilities at its Bethesda, Maryland campus. These systems are essential for high-throughput processing in infectious disease research, particularly for single cell-based antibody discovery and RNA/DNA processing, which are critical for pandemic preparedness. Interested vendors must submit their quotes by 12:00 pm EST on September 26, 2024, including detailed specifications and compliance with federal regulations, to Daveta H. Brown at daveta.brown@nih.gov.
    Downstream Development Biolayer Interferometer Instrument: GatorPivot 16 Channel and Gator Pro 32 Channel Systems- Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for the procurement of two Biolayer Interferometer Instruments, namely the GatorPivot 16 Channel and Gator Pro 32 Channel systems, to support monoclonal antibody and vaccine development projects. The instruments are critical for high-throughput quantification of proteins and protein epitopes, essential for vaccine efficacy and regulatory approval processes. Interested vendors must submit their quotes by September 13, 2024, with the expectation of delivery within 90 days post-award, and are encouraged to demonstrate their capability to meet the specified technical requirements. For inquiries, vendors can contact Hershea Vance at hershea.vance@nih.gov or Linda Smith at linda.smith2@nih.gov.
    Genomics Sequencing Services for the NIAID Centralized Sequencing Program
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for genomics sequencing services to support its Centralized Sequencing Program (CSP). The procurement aims to provide comprehensive whole genome sequencing, including variant interpretation and clinical reports, to enhance clinical research on infectious diseases, with results expected within four weeks of sample receipt. This initiative is critical for advancing the understanding of genetic factors in disease and improving patient care through genomic evaluations. Interested vendors must submit their quotes by 3:00 PM EST on September 13, 2024, to the primary contact, Seth Schaffer, at seth.schaffer@nih.gov, with the solicitation number RFQ-NIAID-24-2224314.
    HIGH SPECIFICITY THROUGH MOLECULAR ALLERGENS AUTOMATIC PROCESSING SYSTEM – ALLERGY DIAGNOSTICS EQUIPMENT (AMBIS 2231182)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract for a high specificity molecular allergens automatic processing system, essential for allergy diagnostics. This equipment is crucial for conducting IgE assessment assays as part of ongoing research aimed at understanding immune system activation pathways, particularly in relation to primary immunodeficiencies and infectious diseases. The procurement includes specific items such as the ImageXplorer Bundle and ALEX² Allergy Explorer Kit, with a delivery estimate of 30 days after receipt of order. Interested parties may submit capability statements to Rita Davis at rita.davis@nih.gov by 4:00 PM EST on September 9, 2024, referencing NOI-NIAID-24-2231182.
    Luminescence reader for tissue explants
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking proposals for the procurement of a luminescence reader for tissue explants, aimed at supporting research on dietary interventions in aging mice. The required equipment must provide high-throughput luminometry capabilities for self-luminous tissues, ensuring reliable and real-time measurements over extended periods, which is critical for circadian and longitudinal aging studies. This acquisition is essential for the NIH's ongoing research efforts at the National Institute on Aging, with a firm fixed-price purchase order anticipated to be awarded, and delivery expected within 60 days after receipt of order. Interested vendors must submit their quotations by 11:00 A.M. Eastern on September 9, 2024, to Hashim Dasti at hashim.dasti@nih.gov.
    Cell Analyzers– Brand Name or Equal
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking quotes for the procurement of eight advanced cell analyzers to support the Vaccine Research Center's (VRC) research initiatives. The required analyzers must possess specific capabilities, including at least five lasers with expansion potential, the ability to detect a minimum of 50 parameters, and features that ensure high throughput sampling and compatibility with existing research tools. This acquisition is critical for maintaining data integrity and enhancing the VRC's capacity to conduct complex immunological studies, with a firm-fixed-price purchase order expected to be awarded. Interested vendors must submit their quotes by 3:00 PM EST on September 13, 2024, to Daveta H. Brown at daveta.brown@nih.gov, ensuring compliance with all outlined specifications and requirements.
    ZEISS DISCOVERY V12 DISSECTING AND ZEISS STEMI 305 DISSECTING SCOPE MICROSCOPES
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking quotes for the procurement of Zeiss Discovery V12 Dissecting and Zeiss Stemi 305 Dissecting Scope Microscopes. This acquisition, which falls under the NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, requires specific brand-name equipment to support the National Institute of Allergy and Infectious Diseases (NIAID) in its research activities. The contract will be awarded based on technical capability and price, with a submission deadline of September 16, 2024, at 5:00 PM EST. Interested vendors should direct inquiries to Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D Weidow at weidowjd@niaid.nih.gov, and must submit their offers via the NIH's Simplified Acquisition Submission System (eSASS).
    Notice of Intent: Gemini Bio-GemCell TM Plus Xeno free Reagents
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole-source contract to Gemini Bio for the supply of GemCell™ Plus Xeno-Free reagents, essential for the Center for Cellular Engineering's operations in Bethesda, Maryland. This procurement is critical as the Center relies on these specific reagents for manufacturing human cell and tissue-based products used in clinical trials, which are vital for patient care and treatment protocols. The unique compatibility of Gemini Bio's products with existing manufacturing processes makes them the only viable source, as switching vendors would incur significant costs and delays, potentially impacting patient outcomes. Interested parties may submit capability statements to Sheri Eiri at sheri.eiri@nih.gov by September 8, 2024, at 12:00 PM EST for consideration.
    PacBio Revio Reagents
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking procurement of PacBio Revio Reagents. This solicitation aims to acquire reagents that are critical for various analytical laboratory applications, particularly in the field of genomics and molecular biology. The goods are essential for conducting in vitro diagnostic tests, which play a significant role in research and clinical diagnostics. Interested vendors can reach out to Dorothy L. Maxwell at dorothy.maxwell@nih.gov or call 301-827-7729 for further details regarding the procurement process.